search
Back to results

Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

Primary Purpose

Obesity, Bariatrics, Sleep Apnea Syndromes

Status
Terminated
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Ketofol
Propofol
Saline
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Obesity focused on measuring Ketamine, Propofol, Ketofol, Obese, Upper gastrointestinal endoscopy, Sedation, Bariatric

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • BMI > 30
  • Undergoing an upper gastrointestinal endoscopy

Exclusion Criteria:

  • History of schizophrenia/schizoaffective disorder
  • History of bipolar disorder
  • History of dementia
  • Non-English Speaking
  • History of Glaucoma
  • Craniofacial Abnormalities
  • Epilepsy
  • Allergy to Propofol
  • Allergy to Ketamine
  • Current known intracranial mass/lesion

Sites / Locations

  • Icahn School of Medicine at Mount Sinai

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Ketofol and Propofol

Propofol only

Arm Description

This arm receives a 50mg dose of Ketamine mixed with 100mg of Propofol at the start of their upper endoscopy.

This arm receives 100mg of Propofol mixed with 1mL of saline at the start of the upper gastrointestinal endoscopy.

Outcomes

Primary Outcome Measures

Number of Participants With Gagging Reaction
Number of participants with gagging or "vomit-like" reaction on endoscopic insertion

Secondary Outcome Measures

Number of Participants With Any Type of Airway Obstruction
The Anesthesiologist caring for the patient during the upper endoscopy made note of any obstructive events defined on a scale ranging from the patient audibly snoring (obstructing) to the patient obstructing and requiring assistance such as a chin lift or jaw thrust to relieve the obstruction and continue to move air adequately.
Total Dose of Propofol Used During the Procedure
Propofol doses are logged in the computerized Compurecord system used in the operating room. Patients involved in the study had their total Propofol dose required quantified and compared between groups who received Ketamine and groups who did not.
Total Sedation Required to Allow Initiation of Procedure
Using the computerized record system, the amount of Propofol a patient required to allow for the procedure to start quantified and compared between groups.
Number of Participants With Post-operative Nausea and/or Vomiting
Number of Participants With Emergence Delirium
Number of participants with emergence delirium measured from the procedure end until time of discharge.
Time to Recovery
Monitored via the electronic medical record system as the time between the anesthesia end time and when the patient was safe for discharge from the hospital.

Full Information

First Posted
December 22, 2015
Last Updated
January 28, 2020
Sponsor
Icahn School of Medicine at Mount Sinai
search

1. Study Identification

Unique Protocol Identification Number
NCT02643979
Brief Title
Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy
Official Title
Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Terminated
Why Stopped
Lack of Enrollment
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
January 5, 2019 (Actual)
Study Completion Date
January 5, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Icahn School of Medicine at Mount Sinai

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Propofol is one of the most popular anesthetic drugs used for sedation during upper gastrointestinal endoscopies due to its quick onset and quick resolution of symptoms allowing patients to leave the hospital sooner. However, when administered it can also slow the breathing of patients and cause others to have upper airway obstruction (such as snoring) which can impede proper spontaneous breathing. Ketamine is an agent that is capable of providing both pain control and sedation while having either minimal effect on breathing or promoting spontaneous breathing. Combining Ketamine with Propofol has the potential to reduce the total amount of Propofol used resulting in a procedure being performed under the same level of sedation but without the downside of reduced spontaneous breathing. Patients who are obese (defined as body mass index greater than 35) tend to be even more susceptible to this effect of Propofol. The researchers are investigating whether the addition of Ketamine will indeed allow for this continued comfortable level of sedation while promoting continued spontaneous breathing in obese patients undergoing upper gastrointestinal endoscopies.
Detailed Description
Upon patient arrival to endoscopy suite heart rate (HR), pre-procedure baseline blood pressure (BP), and pre-procedure oxygen saturation (SPO2) via pulse oximeter are recorded in endoscopy holding area, patient alertness and orientation assessed (respond to name, know the state, know the hospital, know the year, know the season). Once the subject enters the endoscopy suite monitors are placed to record starting BP, HR, SPO2 recorded, nasal cannula with end tidal carbon dioxide (CO2) monitor attached, and 5-lead ECG. Following time out patient given 100mg Lidocaine IV bolus, 1-minute delay, then study-provided syringe administered. Once patient assessed to produce an RSS score >5 (Asleep with sluggish response to glabellar tap or NO response) endoscopy proceeds. Recorder (blinded) notes if initially provided syringe alone was enough to produce an RSS >5, notes subject's response to endoscopy insertion (presence or absence of gagging), notes amount of additional propofol required to maintain adequate conditions to continue endoscopy, records non-invasive blood pressure (NIBP) at 3-minute intervals, notes for level of airway obstruction (obstruction with continued air movement, obstruction requiring chin lift or jaw thrust for relief, obstruction requiring progression to assisted ventilation or intubation), notes for desaturation events (SPO2 <90% with a coherent waveform). At the end of the procedure the total anesthesia time is recorded, total procedure start-to-finish time recorded, total dose of propofol recorded, and any incidence of patient agitation noted. Once in recovery the recovery room admission HR, SPO2, NIBP recorded followed by admission +15 minutes HR, SPO2, and NIBP, any incidence of desaturation (<90% SPO2 with waveform) recorded, incidence of airway obstruction (with air movement, requiring airway maneuver, requiring intervention) recorded, time until patient is alert and oriented recorded (response to name, able to state what state they are in, able to state what hospital they are in, able to state the year, able to state the season), time-until-recovered recorded (Modified Aldrete Score > 9), incidence of nausea prior to recovery recorded, incidence of vomiting prior to recovery recorded, incidence of agitation or delirium prior to recovery recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Bariatrics, Sleep Apnea Syndromes, Gastric Bypass, Endoscopy
Keywords
Ketamine, Propofol, Ketofol, Obese, Upper gastrointestinal endoscopy, Sedation, Bariatric

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ketofol and Propofol
Arm Type
Experimental
Arm Description
This arm receives a 50mg dose of Ketamine mixed with 100mg of Propofol at the start of their upper endoscopy.
Arm Title
Propofol only
Arm Type
Active Comparator
Arm Description
This arm receives 100mg of Propofol mixed with 1mL of saline at the start of the upper gastrointestinal endoscopy.
Intervention Type
Drug
Intervention Name(s)
Ketofol
Other Intervention Name(s)
Ketamine and Propofol, Ketalar, Diprivan
Intervention Description
50mg of Ketamine mixed with 100mg of Propofol
Intervention Type
Drug
Intervention Name(s)
Propofol
Other Intervention Name(s)
Diprivan
Intervention Description
100mg of Propofol
Intervention Type
Drug
Intervention Name(s)
Saline
Intervention Description
1mL of saline
Primary Outcome Measure Information:
Title
Number of Participants With Gagging Reaction
Description
Number of participants with gagging or "vomit-like" reaction on endoscopic insertion
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Number of Participants With Any Type of Airway Obstruction
Description
The Anesthesiologist caring for the patient during the upper endoscopy made note of any obstructive events defined on a scale ranging from the patient audibly snoring (obstructing) to the patient obstructing and requiring assistance such as a chin lift or jaw thrust to relieve the obstruction and continue to move air adequately.
Time Frame
Day 1
Title
Total Dose of Propofol Used During the Procedure
Description
Propofol doses are logged in the computerized Compurecord system used in the operating room. Patients involved in the study had their total Propofol dose required quantified and compared between groups who received Ketamine and groups who did not.
Time Frame
Day 1
Title
Total Sedation Required to Allow Initiation of Procedure
Description
Using the computerized record system, the amount of Propofol a patient required to allow for the procedure to start quantified and compared between groups.
Time Frame
Day 1
Title
Number of Participants With Post-operative Nausea and/or Vomiting
Time Frame
up to 6 months
Title
Number of Participants With Emergence Delirium
Description
Number of participants with emergence delirium measured from the procedure end until time of discharge.
Time Frame
Day 1
Title
Time to Recovery
Description
Monitored via the electronic medical record system as the time between the anesthesia end time and when the patient was safe for discharge from the hospital.
Time Frame
Day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: BMI > 30 Undergoing an upper gastrointestinal endoscopy Exclusion Criteria: History of schizophrenia/schizoaffective disorder History of bipolar disorder History of dementia Non-English Speaking History of Glaucoma Craniofacial Abnormalities Epilepsy Allergy to Propofol Allergy to Ketamine Current known intracranial mass/lesion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel J Katz, MD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
David A Maerz, MD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Study Director
Facility Information:
Facility Name
Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
25197112
Citation
Tandon M, Pandey VK, Dubey GK, Pandey CK, Wadhwa N. Addition of sub-anaesthetic dose of ketamine reduces gag reflex during propofol based sedation for upper gastrointestinal endoscopy: A prospective randomised double-blind study. Indian J Anaesth. 2014 Jul;58(4):436-41. doi: 10.4103/0019-5049.138981.
Results Reference
background
PubMed Identifier
24976998
Citation
Dal T, Sazak H, Tunc M, Sahin S, Yilmaz A. A comparison of ketamine-midazolam and ketamine-propofol combinations used for sedation in the endobronchial ultrasound-guided transbronchial needle aspiration: a prospective, single-blind, randomized study. J Thorac Dis. 2014 Jun;6(6):742-51. doi: 10.3978/j.issn.2072-1439.2014.04.10.
Results Reference
background
PubMed Identifier
24755240
Citation
Street MH, Gerard JM. A fixed-dose ketamine protocol for adolescent sedations in a pediatric emergency department. J Pediatr. 2014 Sep;165(3):453-8. doi: 10.1016/j.jpeds.2014.03.021. Epub 2014 Apr 20.
Results Reference
background
PubMed Identifier
18660398
Citation
Newton A, Fitton L. Intravenous ketamine for adult procedural sedation in the emergency department: a prospective cohort study. Emerg Med J. 2008 Aug;25(8):498-501. doi: 10.1136/emj.2007.053421.
Results Reference
background
PubMed Identifier
22147144
Citation
Sih K, Campbell SG, Tallon JM, Magee K, Zed PJ. Ketamine in adult emergency medicine: controversies and recent advances. Ann Pharmacother. 2011 Dec;45(12):1525-34. doi: 10.1345/aph.1Q370. Epub 2011 Dec 6.
Results Reference
background
PubMed Identifier
18922416
Citation
Pambianco DJ. Future directions in endoscopic sedation. Gastrointest Endosc Clin N Am. 2008 Oct;18(4):789-99, x. doi: 10.1016/j.giec.2008.06.004.
Results Reference
background

Learn more about this trial

Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

We'll reach out to this number within 24 hrs